Shanghai Fosun Pharmaceutical acquired a 5.19% stake in Impax Laboratories Inc. (Nasdaq: IPXL). The stock price leaped $3.70 to close at $21.65.
Shanghai Fosun Pharmaceutical takes stake in Impax Labs
August 31, 2017 at 17:22 PM EDT
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.